| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
GuideWell Source is a leading administrative services company providing full-service, end-to-end business services for health plans and government sponsored health care programs.
Collaborative Imaging is a radiologist owned alliance conceived by forward thinking physicians in conjunction with proven business experts to combat the growing threat of consolidation in radiology, degradation in patient care, physician burn-out, and operational inefficiencies plaguing radiologists, while providing a sustainable business model to allow its partners to realize additional revenue opportunities, all while retaining their full autonomy as an independent radiology practice.
CorEMR is a Midway, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Washington and West is a Towson, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.